GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » Cyclically Adjusted Book per Share

Sartorius Stedim Biotech (STU:56S1) Cyclically Adjusted Book per Share : €14.69 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted book value per share for the three months ended in Dec. 2023 was €28.621. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €14.69 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Sartorius Stedim Biotech's average Cyclically Adjusted Book Growth Rate was 21.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-21), Sartorius Stedim Biotech's current stock price is €197.70. Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €14.69. Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio of today is 13.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sartorius Stedim Biotech was 37.10. The lowest was 11.68. And the median was 19.69.


Sartorius Stedim Biotech Cyclically Adjusted Book per Share Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted Book per Share Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 12.23 14.69

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.23 13.89 13.47 14.17 14.69

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio falls into.



Sartorius Stedim Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=28.621/123.7729*123.7729
=28.621

Current CPI (Dec. 2023) = 123.7729.

Sartorius Stedim Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201012 3.576 94.132 4.702
201106 3.634 95.158 4.727
201112 4.284 95.998 5.524
201206 4.405 96.744 5.636
201212 4.228 97.957 5.342
201306 4.395 98.516 5.522
201312 4.678 99.356 5.828
201406 4.770 99.543 5.931
201412 5.778 99.543 7.184
201506 6.317 100.417 7.786
201512 6.957 99.717 8.635
201606 7.278 100.717 8.944
201612 8.223 101.217 10.055
201706 8.644 102.117 10.477
201709 0.000 102.717 0.000
201712 9.460 102.617 11.410
201803 0.000 102.917 0.000
201806 9.951 104.017 11.841
201809 10.497 104.718 12.407
201812 11.243 104.217 13.353
201903 11.356 104.217 13.487
201906 11.924 105.718 13.960
201909 12.670 106.018 14.792
201912 12.571 105.818 14.704
202003 13.309 105.718 15.582
202006 13.657 106.618 15.854
202009 14.615 105.818 17.095
202012 15.601 105.518 18.300
202103 16.608 107.518 19.119
202106 18.101 108.486 20.652
202109 18.099 109.435 20.470
202112 17.964 110.384 20.143
202203 20.866 113.968 22.661
202206 22.260 115.760 23.801
202209 24.660 118.818 25.688
202212 26.575 119.345 27.561
202303 26.261 122.402 26.555
202306 27.879 123.140 28.022
202309 28.153 124.195 28.057
202312 28.621 123.773 28.621

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Sartorius Stedim Biotech  (STU:56S1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=197.70/14.69
=13.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sartorius Stedim Biotech was 37.10. The lowest was 11.68. And the median was 19.69.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sartorius Stedim Biotech Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (STU:56S1) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech (STU:56S1) Headlines

No Headlines